Medtronic Analyst Price Targets - Benzinga

Medtronic PLC

MDTNYSE

Trade with Public

Trade with Public

$94.17

1.071.15%

At close: Sep 4, 5:00 PM EST

$94.10

-0.07-0.07%

After Hours: Sep 4, 7:18 PM EST

Earnings: Q1 2027 Earnings were released on Tue Sep 1st, before the market open

Conference Call: The most recent conference call started at 7:45 AM, 6 days ago

Click to view the webcast

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Medtronic Analyst Price Targets

Wall Street analyst price targets and consensus rating for Medtronic (MDT).

Price Target Range — 8 Quarters

Analyst Consensus — 22 Analysts

16Buy

6Hold

Consensus RatingBuy# Analysts22Avg. Consensus PT$105Upside to Avg. PT+12.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 3, 2026	UBS	Priya Sachdeva	PT Raise	Buy	$100→$110
Sep 2, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$86→$99
Sep 2, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$102→$104
Sep 2, 2026	RBC Capital	Kendall Au	Maintained	Outperform	$118
Sep 2, 2026	B of A Securities	Bob Hopkins	PT Raise	Buy	$95→$110
Sep 2, 2026	Stifel	Rick Wise	PT Raise	Hold	$80→$95
Sep 2, 2026	Baird	David Rescott	PT Raise	Neutral	$91→$100
Sep 1, 2026	Needham	Mike Matson	Maintained	Buy	$114
Sep 1, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$91→$100
Aug 28, 2026	TD Cowen	Joshua Jennings	PT Raise	Buy	$100→$110
Aug 27, 2026	Needham	Mike Matson	PT Raise	Buy	$101→$114
Aug 18, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$91
Jul 28, 2026	UBS	Priya Sachdeva	Upgrade	Neutral→Buy	$85→$100
Jul 10, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$119→$100
Jul 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$106→$105
Jun 17, 2026	Needham	Mike Matson	Maintained	Buy	$101
Jun 5, 2026	Goldman Sachs	David Roman	PT Cut	Neutral	$84→$83
Jun 5, 2026	Bernstein	Lee Hambright	PT Cut	Outperform	$112→$97
Jun 4, 2026	UBS	Priya Sachdeva	PT Cut	Neutral	$90→$85
Jun 4, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$119

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on Medtronic, Raises Price Target to $110

UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $100 to $110.

Benzinga Newsdesk

PRO
Truist Securities Reiterates Hold on Medtronic, Raises Price Target to $99

Truist Securities analyst Richard Newitter reiterates Medtronic (NYSE:MDT) with a Hold and raises the price target from $86 to $99.

Benzinga Newsdesk

Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection

MDT shares rise after Q1 beat and raised FY27 growth guidance. Analysts maintain Buy/Outperform ratings, citing broad-based strength.

Priya Nigam

PRO
Wells Fargo Maintains Overweight on Medtronic, Raises Price Target to $104

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $102 to $104.

Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on Medtronic, Maintains $118 Price Target

RBC Capital analyst Kendall Au reiterates Medtronic (NYSE:MDT) with a Outperform and maintains $118 price target.

Benzinga Newsdesk

Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Cantor Fitzgerald raised

Avi Kapoor